On this page, we show you all research publications of the TIMESPAN consortium. These publications report on the research output of the project. For each publication, we provide a brief summary. To read the full article, imply click on the title of the publication.
TIMESPAN publications (count: 10)
2022
- Bruno C, Havard A, Gillies MB, Coghill D, Brett J, Guastella AJ, Pearson S-A, Zoega H (2022). Patterns of attention deficit hyperactivity disorder medicine use in the era of new non-stimulant medicines: A population-based study among Australian children and adults (2013–2020). The Australian and New Zealand Journal of Psychiatry. doi: https://doi.org/10.1177/00048674221114782
- Daly MJ, Singh, T, Poterba T, Curtis D, Akil H, Al Eissa M, Barchas JD, Bass N, Bigdeli TB, Breen G, Bromet EJ, Buckley PF, Bunney WE, Bybjerg-Grauholm J, Byerley WF, Chapman SB, Chen WJ, Churchhouse C, Craddock N, Cusick CM, DeLisi L, Dodge S, Escamilla MA, Eskelinen S, Fanous AH, Faraone SV, Fiorentino A, Francioli S, Gabriel SB, Gage D, Gagliano Taliun SA, Ganna A, Genovese G, Glahn DC, Grove J, Hall MH, Hämäläinen E, Heyne HO, Holi M, Hougaard DM, Howrigan DP, Huang H, Hwu HG, Kahn RS, Kang HM, Karczewski KJ, Kirov G, Knowles JA, Lee FS, Lehrer DS, Lescai F, Malaspina D, Marder SR, McCarroll SA, McIntosh AM, Medeiros H, Milani L, Morley CP, Morris DW, Mortensen PB, Myers RM, Nordentoft M, O’Brien NL, Olivares AM, Ongur D, Ouwehand WH, Palmer DS, Paunio T, Quested D, Rapaport MH, Rees E, Rollins B, Satterstrom FK, Schatzberg A, Scolnick E, Scott LJ, Sharp SI, Sklar P, Smoller JW, Sobell JL, Solomonson M, Stahl EA, Stevens CR, Suvisaari J, Tiao G, Watson SJ, Watts NA, Blackwood DH, Børglum AD, Cohen BM, Corvin AP, Esko T, Freimer NB, Glatt SJ, Hultman CM, McQuillin A, Palotie A, Pato CN, Pato MT, Pulver AE, St Clair D, Tsuang MT, Vawter MP, Walters JT, Werge TM, Ophoff RA, Sullivan PF, Owen MJ, Boehnke M, O’Donovan MC, Neale BM. Rare coding variants in ten genes confer substantial risk for schizophrenia. Nature. 604, pages 509–516. doi: https://doi.org/10.1038/s41586-022-04556-w
- Dobrosavljevic M, Fazel S, Du Rietz E, Li L, Zhang L, Chang Z, Jernberg T, Faraone SV, Jendle J, Chen Q, Brikell I, Larsson H (2022). Risk prediction model for cardiovascular diseases in adults initiating pharmacological treatment for attention-deficit/hyperactivity disorder. Evidence-Based Mental Health. Published Online First: 05 September 2022.
- Garcia-Argibay M, Du Rietz E, Hartman CA, Lichtenstein P, Chang Z, Fava C, Cortese S, Larsson H (2022). Cardiovascular risk factors in attention deficit/hyperactivity disorder: A family design study of Swedish conscripts. International Journal of Methods in Psychiatric Research. 31(4):e1930. doi: 10.1002/mpr.1930. Epub 2022 Jun 29.
- Garcia-Argibay M, du Rietz E, Lu Y, Martin J, Haan E, Lehto K, Bergen SE, Lichtenstein P, Larsson H & Brikell I (2022). The role of ADHD genetic risk in mid-tolate life somatic health conditions. Translational Psychiatry. 12, 152. doi: https://doi.org/10.1038/s41398-022-01919-9
- Heslin KP, Haruna A, George RA, Chen S, Nobel I, Anderson KB, Faraone SV, Zhang-James Y (2022). Association Between ADHD and COVID-19 Infection and Clinical Outcomes: A Retrospective Cohort Study From Electronic Medical Records. Journal of Attention Disorders. Jan;27(2):169-181. doi: 10.1177/10870547221129305.
- Hou, J, Hess JL, Armstrong N, Bis JC, Grenier-Boley B, Karlsson IK, Leonenko G, Numbers K, O’Brien EK, Shadrin A, Thalamuthu A, Yang Q, Andreassen OA, Brodaty H, Gatz M, Kochan NA, Lambert JC, Laws SM, Masters CL, Mather KA, Pedersen NL, Posthuma D, Sachdev PS, Williams J, Fan CC, Faraone SV, Fennema-Notestine C, Lin SJ, Escott-Price V, Holmans P, Seshadri S, Tsuang MT, Kremen WS, Glatt SJ (2022). Polygenic resilience scores capture protective genetic effects for Alzheimer’s disease. Translational Psychiatry. 12 (296). doi: https://doi.org/10.1038/s41398-022-02055-0
- Li L, Chang Z, Sun J, Garcia-Argibay M, Du Rietz E, Dobrosavljevic M, Brikell I, Jernberg T, Solmi M, Cortese S, Larsson H (2022). Attention-deficit/hyperactivity disorder as a risk factor for cardiovascular diseases: a nationwide population-based cohort study. World Psychiatry. 21 (3): pp. 452-459.
- Stenberg E, Larsson H, Marsk R, Cao Y, Sundbom M, Näslund E (2022). Association between Attention Deficit Hyperactivity Disorder and outcomes after metabolic and bariatric surgery: a nationwide propensity matched cohort study. Surgery for Obesity and Related Diseases. 19(2): pp. 92-100. doi: https://doi.org/10.1016/j.soard.2022.10.028
- Zhang L, Yao H, Li L, du Rietz E, Andell P, Garcia-Argibay M, D’Onofrio BM, Cortese S, Larsson H (2022). Risk of Cardiovascular Diseases Associated With Medications Used in Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-analysis. JAMA Network Open. 2022;5(11):e2243597. doi: doi:10.1001/jamanetworkopen.2022.43597
